Teams at Lyell Immunopharma

Provide QA leadership and oversight across cell therapy product lifecycle activities including PPQ/validation for LVV, plasmids and drug product; partner with CDMOs and cross-functional teams for process implementation, tech transfer, regulatory submission (IND/BLA) support, inspection readiness, and management of deviations, CAPAs, and change controls to ensure GMP compliance.

Leads FP&A activities including budgeting, forecasting, monthly reporting, variance analysis, financial modeling, KPI tracking, and performance management. Partners with R&D, Clinical, G&A, Commercial, HR, Accounting, and other leaders to assess spending, headcount, CRO and vendor costs, and business drivers. Improves FP&A systems, reporting, data integration, automation, forecasting methodologies, and financial discipline while providing actionable insights for resource allocation and decision-making.

Lead strategic and operational execution of clinical development programs from Phase 1 through approval and lifecycle management. Coordinate cross-functional teams across clinical operations, CMC, regulatory, biometrics, quality, pharmacovigilance, finance, and external vendors. Own integrated plans, timelines, budgets, risks, resources, governance, reporting, and submission readiness for IND, BLA, NDA, and MAA milestones. Mentor project managers, improve clinical program management processes, and support cell therapy or oncology development programs.